First in Human Trial to Assess the Feasibility and Preliminary Safety of Adjunctive Treatment with the HemoSystem REBOOT in Critically Ill Patients with Sepsis-induced Immunosuppression
Clinical trial NCT06258291 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06258291
- Sponsor
- hemotune AG
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2026-07-28
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.